Global private equity and venture capital news and research

Great Point backs temp-controlled package business Softbox through growth recap

8 Jul 2014

SoftboxHealthcare-focused investment firm Great Point Partners has made a growth recapitalisation of UK temperature-controlled packaging business Softbox.

The company provides packaging for the biotech and pharmaceutical industries to help them transport temperature-sensitive drugs, vaccines and active pharmaceutical ingredients.

Great Point managing director Adam Dolder said, “Softbox presented a compelling opportunity to invest in a global leader in the market of TCP solutions for the biopharmaceutical industry.

“Management’s deep domain knowledge and commitment to innovation of new solutions for their customers have created a unique platform in the industry.

“[CEO Richard Jones] and Edwin Tattam, founder, have developed a company with extraordinary customer satisfaction and durable, long-term relationships with its customers.”

Last October Great Point Partners secured additional commitments for its second fund and confirmed that Wedge Alternatives was acting as a placement agent for the vehicle.

Great Point Partners II had raised $150.3m from 105 LPs, up from $139.6m in July last year, the firm revealed in a document filed with US securities regulators.

Copyright © 2014 AltAssets


Legals & Terms of UsePrivacy Policy

AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: Zetland House, 5-25 Scrutton St, London EC2A 4HJ
Content is © AltAssets 2000-2015